OS Therapies Incorporated
OSTX
$2.00
$0.189.89%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M |
| Total Depreciation and Amortization | 1.40K | 0.00 | 700.00 | 700.00 | 0.00 |
| Total Amortization of Deferred Charges | 0.00 | 338.30K | 508.70K | 578.70K | 213.20K |
| Total Other Non-Cash Items | 301.80K | -- | -- | -- | 0.00 |
| Change in Net Operating Assets | 313.40K | -847.90K | 166.90K | 237.80K | 380.20K |
| Cash from Operations | -2.37M | -3.38M | -881.20K | -641.70K | -871.20K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 0.00 | 0.00 | 900.00K | 851.00K | 1.07M |
| Total Debt Repaid | 0.00 | -250.00K | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 5.23M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.05M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 172.10K | -24.10K | -148.00K | -175.90K |
| Cash from Financing | 6.05M | 5.15M | 875.90K | 703.00K | 894.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.68M | 1.76M | -5.30K | 61.20K | 22.90K |